Notox Technologies Corp.
NTOX
Other OTC0.10
USD
- -
- -
Notox Technologies Corp.
NTOX
(Other OTC)
Recent
price
0.10
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Notox Technologies Corp. (NTOX) develops, commercializes, and distributes medical and beauty products focused on non-invasive aesthetic treatments and drug-free solutions. The company offers its patented Notox platform, a non-toxic alternative to Botox for cosmetic procedures including wrinkle reduction, skin tightening, and body contouring; drug-free pain management applications; migraine relief; perspiration control; and home mist tanning units designed for spas, gyms, clinics, and consumer use. It operates primarily in the personal care and aesthetics industry, targeting clinics, spas, and individual consumers with distribution capabilities for additional medical and beauty products across North America. Founded in 2007 and headquartered in Richmond Hill, Ontario, Canada, the company pursues expansion through strategic distribution networks in Canada and beyond. Notox Technologies Corp., formerly Tropic International Inc., changed its name in November 2018 to reflect its focus on the Notox technology platform. In December 2019, it completed the acquisition of assets from Xthetica Inc., a Canadian distributor of aesthetic and medical beauty products, gaining access to over 300 clinics and rights to distribute various beauty lines. The company continues to advance regulatory efforts, including engagement of RQM+ in May 2021 for USFDA approval processes related to its Notox apparatus.